Changcheng Zheng

1.4k total citations
65 papers, 743 citations indexed

About

Changcheng Zheng is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Changcheng Zheng has authored 65 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hematology, 15 papers in Oncology and 11 papers in Genetics. Recurrent topics in Changcheng Zheng's work include Hematopoietic Stem Cell Transplantation (24 papers), Acute Myeloid Leukemia Research (22 papers) and Polyomavirus and related diseases (8 papers). Changcheng Zheng is often cited by papers focused on Hematopoietic Stem Cell Transplantation (24 papers), Acute Myeloid Leukemia Research (22 papers) and Polyomavirus and related diseases (8 papers). Changcheng Zheng collaborates with scholars based in China, Hong Kong and France. Changcheng Zheng's co-authors include Hui Guo, Jinquan Wang, Zhaohui Lu, Zimin Sun, Mingming Fei, Fei Tong, Baolin Tang, Huilan Liu, Xiaoyu Zhu and Hongliang He and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Changcheng Zheng

51 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changcheng Zheng China 14 340 290 168 146 82 65 743
Moussab Damlaj Saudi Arabia 13 190 0.6× 193 0.7× 136 0.8× 91 0.6× 67 0.8× 65 625
Ioannis Mantzaris United States 12 248 0.7× 182 0.6× 363 2.2× 40 0.3× 63 0.8× 70 812
Robert Q. Le United States 8 216 0.6× 131 0.5× 397 2.4× 163 1.1× 46 0.6× 16 755
Christopher Leveque United States 12 203 0.6× 157 0.5× 49 0.3× 89 0.6× 71 0.9× 27 659
Kiat Hoe Ong Singapore 14 182 0.5× 210 0.7× 170 1.0× 58 0.4× 23 0.3× 35 720
Kyle McBride Italy 10 144 0.4× 143 0.5× 299 1.8× 64 0.4× 111 1.4× 17 814
Elisabetta Calore Italy 17 230 0.7× 406 1.4× 241 1.4× 31 0.2× 86 1.0× 37 869
Sebastian Birndt Germany 7 534 1.6× 615 2.1× 106 0.6× 107 0.7× 27 0.3× 10 909
Valérie Coiteux France 16 142 0.4× 351 1.2× 244 1.5× 36 0.2× 83 1.0× 55 836
Odelia Amit Israel 13 97 0.3× 167 0.6× 278 1.7× 28 0.2× 54 0.7× 39 525

Countries citing papers authored by Changcheng Zheng

Since Specialization
Citations

This map shows the geographic impact of Changcheng Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changcheng Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changcheng Zheng more than expected).

Fields of papers citing papers by Changcheng Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changcheng Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changcheng Zheng. The network helps show where Changcheng Zheng may publish in the future.

Co-authorship network of co-authors of Changcheng Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Changcheng Zheng. A scholar is included among the top collaborators of Changcheng Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changcheng Zheng. Changcheng Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Yue, et al.. (2025). Dysregulated glutathione metabolism impairs natural killer cell function in patients with acute leukemia. International Immunopharmacology. 154. 114566–114566. 1 indexed citations
2.
Xue, Feng, Tienan Zhu, Zeping Zhou, et al.. (2025). Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials. Nature Medicine. 32(1). 93–102.
3.
Xu, Zhenyu, et al.. (2025). Detection of nontoxic BoNT/A levels in post-facial Botox injection breastmilk. PubMed. 4. 1480515–1480515. 1 indexed citations
4.
Sun, Guangyu, Jiyuan Tu, Baolin Tang, et al.. (2025). Adoptive transfer of third‐party donor CMV ‐specific T cells for refractory cytomegalovirus infection following umbilical cord blood transplantation. British Journal of Haematology. 207(5). 2072–2079.
5.
6.
Wang, Yan, Yue Zhao, Dan Liu, et al.. (2024). Thrombopoietin receptor agonists regulate myeloid-derived suppressor cell-mediated immunomodulatory effects in ITP. Annals of Hematology. 103(8). 2729–2741. 1 indexed citations
7.
Wang, Yan, Beibei Huang, Mingming Wu, et al.. (2024). Venetoclax acts as an immunometabolic modulator to potentiate adoptive NK cell immunotherapy against leukemia. Cell Reports Medicine. 5(6). 101580–101580. 9 indexed citations
8.
Wang, Yan, et al.. (2024). Protocol to measure cell avidity between cord blood-derived NK cells and leukemia cell line KG-1a. STAR Protocols. 5(4). 103387–103387.
9.
10.
Wang, Li, Na Zhao, Li Zhou, et al.. (2022). Standard-Intensity Induction and Intermediate/High-Dose Cytarabine Consolidation Can Improve Survival for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Cohort Study. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Guo, Hui, Yinguang Fan, Zichen Song, et al.. (2021). The Cytokine Profiles and Immune Response Are Increased in COVID-19 Patients with Type 2 Diabetes Mellitus. Journal of Diabetes Research. 2021. 1–8. 35 indexed citations
12.
Tong, Juan, Na Zhao, Xing Hu, et al.. (2021). Efficacy of Venetoclax Combined with Decitabine-Based Treatment for Heavily Pre-Treated Relapsed or Refractory AML Patients in a Real-World Setting. Cancer Management and Research. Volume 13. 5613–5621. 8 indexed citations
13.
Tang, Baolin, Xiaoyu Zhu, Siqi Cheng, et al.. (2020). <p>Protective Effects of Cytomegalovirus DNA Copies ≧1000/mL for AML Patients in Complete Remission After Single Cord Blood Transplantation</p>. Infection and Drug Resistance. Volume 13. 373–383. 4 indexed citations
14.
Tong, Fei, Mingming Fei, Hui Guo, et al.. (2020). First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab. Blood Advances. 4(7). 1307–1310. 176 indexed citations
15.
Zhou, Li, Xinhui Zhang, Na Zhao, et al.. (2020). <p>Urgent Chemotherapy Successfully Rescues a Near Death Patient of Acute Intracranial Hypertension Caused by Intracranial Myeloid Sarcoma</p>. OncoTargets and Therapy. Volume 13. 237–241. 2 indexed citations
16.
Wang, Yong, et al.. (2020). <p>Clinical Features and Short-Term Outcomes in COVID-19-Infected Patients with Cancer</p>. Cancer Management and Research. Volume 12. 12021–12028.
17.
18.
Zhu, Xiaoyu, Lulu Huang, Changcheng Zheng, et al.. (2017). European Group for Blood and Marrow Transplantation Risk Score Predicts the Outcome of Patients with Acute Leukemia Receiving Single Umbilical Cord Blood Transplantation. Biology of Blood and Marrow Transplantation. 23(12). 2118–2126. 10 indexed citations
19.
Zheng, Changcheng, Baolin Tang, Xiaoyu Zhu, et al.. (2016). Pre-engraftment bloodstream infections in acute leukemia patients undergoing unrelated cord blood transplantation following intensified myeloablative conditioning without ATG. Annals of Hematology. 96(1). 115–124. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moussab Damlaj Breakdown of academic impact, for papers by Ioannis Mantzaris Breakdown of academic impact, for papers by Robert Q. Le Breakdown of academic impact, for papers by Christopher Leveque Breakdown of academic impact, for papers by Kiat Hoe Ong Breakdown of academic impact, for papers by Kyle McBride Breakdown of academic impact, for papers by Elisabetta Calore Breakdown of academic impact, for papers by Sebastian Birndt Breakdown of academic impact, for papers by Valérie Coiteux Breakdown of academic impact, for papers by Odelia Amit
Rankless by CCL
2026